The Foundation will award a maximum of $100,000 annually, to seek out potential cures for cancer or to alleviate the impact of cancer.
Agencies may submit only one proposal per year.
The SAS Foundation accepts grant proposals annually. Proposals are due to the Foundation’s PO Box offices on Tuesday, September 15th, 2016. Proposals postmarked but not received by this date cannot be considered. Early submission is recommended so that fulfillment of foundation guidelines can be met. Decisions will be announced approximately six to eight weeks after submission.
Please download and print the PDF below:
Summary of Grants Given
The Advisory Committee and Board have approved $50,000 Grants for the following:
To Roswell Park Alliance Foundation (Grantee) for MicroRNA expression profiling recurrence after resection of stage 1 Non-Small Cell Lung Cancer Project. This grant, #HHS-0001-09SF, is being made in response to proposal submitted in September 2009. Grant period for this award is December 18, 2009 through December 2011.
To Roswell Park Alliance Foundation (Grantee) for the identification of genes essential for mammary, pancreatic, epithelia, and melanocytes as potential targets for cancer therapy. This grant, #HHS-0002-10SF, is being made in response to proposal submitted August 2010. The grant period for this award is December 3, 2010 through December 2012.
To Yale School of Medicine (Grantee) for the small molecule Magmas inhibitor (SMMI) pharmacokinests, and evaluation as a cancer treatment and imaging agent. This grant, #HHS-0003-11SF, is being made in response to proposal submitted September 2011. The grant period for this award is November 23, 2011 through December 2013.
To Children's Hospital of Philadelphia (Grantee) for the "A Novel Approach to Enhance and redirect the anti-Leukemia Properties of human Invariant Natural Killer T cells", to develop new ways to stimulate the immune system to more effectively treat different types of cancer. This grant, "HHS-0004-12SF, is being made in in response to proposal submitted in October 2012. The grant period for this award is November 9, 2012 through December 2014.
To Albert Einstein College of Medicine of Yeshiva University (Grantee) for the “Characterizing Magmas regulation and determining its role in energy metabolism and cancer treatment”. This grant, #HHS-0005-14SF, is being made in response to your organization’s original proposal submitted in November 2013 with final requested documentation received in January 2014. The grant period for this award is March 15, 2014 through December 2015.
To Roswell Park Alliance Foundation/Roswell Park Cancer Institute (Grantee) for the Inhibiting androgen deprivation therapy-induced sarcopenia in prostate cancer (prevention of castration-induced muscle loss in prostate cancer). This grant, #HHS-0006-15SF, is being made in response to your organization’s original proposal submitted in September 2015. The grant period for this award is November 25, 2015 through December 31, 2016.